Nifedipine Relonchem (Nifedipine)

Nifedipine selectively blocks L‑type calcium channels in vascular smooth muscle and cardiac myocytes. By preventing calcium entry, the drug relaxes arterial smooth muscle, producing dose‑dependent vasodilation, lowering systemic vascular resistance, and improving coronary blood flow. This mechanism reduces arterial pressure and myocardial oxygen demand, providing antihypertensive and anti‑anginal effects.

The appropriate dose of Nifedipine Relonchem is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concomitant medications. Dosage may be adjusted during treatment to achieve target blood pressure or symptom control, and patients should follow the specific instructions provided on the prescription label.

Safety data for nifedipine in pregnancy are limited, and the drug is classified as a category where benefits must outweigh potential risks. It is generally avoided unless clearly needed. Nifedipine is excreted in breast milk, so nursing mothers should consult their health‑care provider before using the medication to assess risk to the infant.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifying trade or institutional credentials before providing a formal quotation, confirming availability, shipping terms (including any temperature‑controlled logistics), and necessary import documentation.

Compared with beta‑blockers or ACE inhibitors, nifedipine primarily induces vasodilation through calcium‑channel blockade, leading to rapid blood pressure reduction. It is especially useful in patients with peripheral vascular disease or angina, whereas beta‑blockers reduce heart rate and ACE inhibitors affect the renin‑angiotensin system. Choice of therapy depends on comorbidities, tolerability, and physician judgment.

Nifedipine Relonchem tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture, light, and excessive heat. Keeping the product in a dry place helps maintain potency throughout its shelf life. Do not refrigerate or freeze the tablets unless specifically instructed by the supplier.

The medication is taken orally, usually with a glass of water. Depending on the prescribed regimen, tablets may be taken once daily or in divided doses, and some formulations are designed for extended release. Patients should follow the dosing schedule indicated on the prescription label and avoid crushing or chewing extended‑release tablets unless directed by a health‑care professional.

Serious adverse events, though uncommon, include severe hypotension, myocardial infarction, atrioventricular block, hepatotoxicity, and life‑threatening allergic reactions such as anaphylaxis. Patients experiencing fainting, chest pain, irregular heartbeats, jaundice, or widespread rash should seek immediate medical attention. Regular monitoring and adherence to prescribed doses help mitigate these risks.

Nifedipine is contraindicated in patients with known hypersensitivity to the drug or any of its excipients, those with severe aortic stenosis, and individuals experiencing cardiogenic shock. Caution is also advised for patients with significant hepatic impairment or uncontrolled heart failure. Clinicians must review the patient’s medical history before initiating therapy to ensure safety.